A detailed history of Gps Wealth Strategies Group, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 8 shares of EDIT stock, worth $23. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 6 33.33%
Holding current value
$23
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$3.39 - $5.96 $6 - $11
2 Added 33.33%
8 $0
Q1 2024

Apr 30, 2024

BUY
$7.03 - $11.07 $42 - $66
6 New
6 $0

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $200M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.